These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18487507)

  • 1. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q.
    Shinawi M; Erez A; Shardy DL; Lee B; Naeem R; Weissenberger G; Chinault AC; Cheung SW; Plon SE
    Blood; 2008 Aug; 112(4):1042-7. PubMed ID: 18487507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patients.
    Katzaki E; Morin G; Pollazzon M; Papa FT; Buoni S; Hayek J; Andrieux J; Lecerf L; Popovici C; Receveur A; Mathieu-Dramard M; Renieri A; Mari F; Philip N
    Am J Med Genet A; 2010 Jul; 152A(7):1711-7. PubMed ID: 20578134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.
    Song WJ; Sullivan MG; Legare RD; Hutchings S; Tan X; Kufrin D; Ratajczak J; Resende IC; Haworth C; Hock R; Loh M; Felix C; Roy DC; Busque L; Kurnit D; Willman C; Gewirtz AM; Speck NA; Bushweller JH; Li FP; Gardiner K; Poncz M; Maris JM; Gilliland DG
    Nat Genet; 1999 Oct; 23(2):166-75. PubMed ID: 10508512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional RUNX1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 ITSN1 as a candidate gene in mental retardation.
    van der Crabben S; van Binsbergen E; Ausems M; Poot M; Bierings M; Buijs A
    Leuk Res; 2010 Jan; 34(1):e8-12. PubMed ID: 19679353
    [No Abstract]   [Full Text] [Related]  

  • 5. Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene.
    Click ES; Cox B; Olson SB; Grompe M; Akkari Y; Moreau LA; Shimamura A; Sternen DL; Liu YJ; Leppig KA; Matthews DC; Parisi MA
    Am J Med Genet A; 2011 Jul; 155A(7):1673-9. PubMed ID: 21626672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
    Antony-Debré I; Manchev VT; Balayn N; Bluteau D; Tomowiak C; Legrand C; Langlois T; Bawa O; Tosca L; Tachdjian G; Leheup B; Debili N; Plo I; Mills JA; French DL; Weiss MJ; Solary E; Favier R; Vainchenker W; Raslova H
    Blood; 2015 Feb; 125(6):930-40. PubMed ID: 25490895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
    Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS
    Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes.
    Burillo-Sanz S; Vargas MT; Morales-Camacho RM; Caballero-Velázquez T; Sánchez J; García-Lozano JR; Pérez de Soto I; Prats-Martín C; Bernal R; Pérez-Simón JA
    Hematol Oncol; 2017 Dec; 35(4):894-899. PubMed ID: 26947932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.
    Antony-Debré I; Bluteau D; Itzykson R; Baccini V; Renneville A; Boehlen F; Morabito M; Droin N; Deswarte C; Chang Y; Leverger G; Solary E; Vainchenker W; Favier R; Raslova H
    Blood; 2012 Sep; 120(13):2719-22. PubMed ID: 22677128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia.
    Weber S; Haferlach C; Jeromin S; Nadarajah N; Dicker F; Noël L; Zenger M; Alpermann T; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2016 Feb; 55(2):148-57. PubMed ID: 26542308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
    Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
    Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neonate with congenital amegakaryocytic thrombocytopenia associated with a chromosomal microdeletion at 21q22.11 including the gene RUNX1.
    Christensen RD; Wiedmeier SE; Yaish HM
    J Perinatol; 2013 Mar; 33(3):242-4. PubMed ID: 23443295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
    Ganly P; Walker LC; Morris CM
    Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
    Nguyen D; Li Y; Safah H; Brown TC
    Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Braddock-Carey syndrome: A 21q22 contiguous gene syndrome encompassing RUNX1.
    Braddock SR; South ST; Schiffman JD; Longhurst M; Rowe LR; Carey JC
    Am J Med Genet A; 2016 Oct; 170(10):2580-6. PubMed ID: 27549381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.
    Béri-Dexheimer M; Latger-Cannard V; Philippe C; Bonnet C; Chambon P; Roth V; Grégoire MJ; Bordigoni P; Lecompte T; Leheup B; Jonveaux P
    Eur J Hum Genet; 2008 Aug; 16(8):1014-8. PubMed ID: 18478040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
    Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
    Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
    Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.